Holen Sie sich die Stockscreener-App
1.51
1.31%
-0.02
Schlusskurs vom Vortag:
$1.53
Offen:
$1.55
24-Stunden-Volumen:
843.80K
Relative Volume:
0.54
Marktkapitalisierung:
$401.88M
Einnahmen:
$92.67M
Nettoeinkommen (Verlust:
$-288.81M
KGV:
-1.3914
EPS:
-1.0852
Netto-Cashflow:
$-295.51M
1W Leistung:
-3.21%
1M Leistung:
-16.11%
6M Leistung:
-3.82%
1J Leistung:
-26.70%
1-Tages-Spanne:
$1.505
$1.59
1-Wochen-Bereich:
$1.46
$1.66
52-Wochen-Spanne:
$1.175
$2.70
Autolus Therapeutics Plc Adr Stock (AUTL) Company Profile
Firmenname
Autolus Therapeutics Plc Adr
Sektor
Branche
Telefon
44 20 3829 6230
Adresse
THE MEDIAWORKS, LONDON
Compare AUTL vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AUTL
Autolus Therapeutics Plc Adr
|
1.51 | 401.88M | 92.67M | -288.81M | -295.51M | -1.0852 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Autolus Therapeutics Plc Adr Stock (AUTL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-11-18 | Hochstufung | Goldman | Neutral → Buy |
| 2024-11-15 | Hochstufung | Redburn Atlantic | Neutral → Buy |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Buy |
| 2023-03-27 | Fortgesetzt | Wells Fargo | Overweight |
| 2023-03-17 | Eingeleitet | Bryan Garnier | Buy |
| 2021-06-14 | Hochstufung | Jefferies | Hold → Buy |
| 2021-01-29 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-12-28 | Fortgesetzt | H.C. Wainwright | Buy |
| 2020-07-31 | Eingeleitet | JP Morgan | Overweight |
| 2020-07-22 | Eingeleitet | SunTrust | Buy |
| 2020-04-22 | Eingeleitet | Mizuho | Buy |
| 2019-09-23 | Eingeleitet | Needham | Buy |
| 2019-05-17 | Bestätigt | H.C. Wainwright | Buy |
| 2018-10-24 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Autolus Therapeutics Plc Adr Aktie (AUTL) Neueste Nachrichten
Autolus Therapeutics (AUTL) could find a support soon, here's why you should buy the stock now - MSN
Autolus Therapeutics Receives Prix Galien UK Award - GlobeNewswire Inc.
Autolus Therapeutics (AUTL) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance
Autolus Therapeutics PLC Sponsored ADR (AUTL) Just Flashed Golden Cross Signal: Do You Buy? - sharewise.com
Apellis Pharmaceuticals (APLS) moves 135.4% higher: Will this strength last? - MSN
Autolus Therapeutics Q1 Earnings Call Highlights - Yahoo Finance
Autolus Therapeutics (NASDAQ: AUTL) to cut 13% of staff, save $15M - Stock Titan
Autolus Therapeutics Eyes CAR-T Edge With AUCATZYL Safety, Expands Centers, Sees Margin Turnaround - Yahoo Finance
Autolus Therapeutics (NASDAQ: AUTL) registers $150M shelf for shares, ADSs, debt - Stock Titan
Autolus Therapeutics Highlights obe-cel Momentum in ALL With New Real-World ROKA and Pediatric Data - Yahoo Finance
Apellis Pharmaceuticals (APLS) Surges 135.4%: Can This Momentum Be Sustained? - Bitget
Apellis Pharmaceuticals (APLS) Moves 135.4% Higher: Will This Strength Last? - Yahoo Finance
Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) Receives $8.50 Consensus Target Price from Analysts - Defense World
Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Autolus Therapeutics Q4 Earnings Call Highlights - Yahoo Finance
Mak Capital One LLC Buys 9,062,518 Shares of Autolus Therapeutics PLC Sponsored ADR $AUTL - MarketBeat
Autolus Therapeutics Touts $75M Year-1 Obe-cel Launch, Sees $120M-$135M Revenue in 2026 - Yahoo Finance
Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
What is HC Wainwright’s Estimate for AUTL FY2025 Earnings? - Defense World
Q1 Earnings Forecast for AUTL Issued By HC Wainwright - MarketBeat
What is HC Wainwright's Estimate for AUTL FY2025 Earnings? - MarketBeat
Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
New Strong Sell Stocks for January 30th - Yahoo Finance
Autolus Therapeutics (NASDAQ:AUTL) Cut to Strong Sell at Zacks Research - Defense World
New Strong Sell Stocks for January 22nd - Yahoo! Finance Canada
Why Gelteq Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket - Benzinga
Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
Truist Securities lowers Autolus Therapeutics stock price target on soft guidance - Investing.com
Free cash flow per share of Autolus Therapeutics Plc Sponsored ADR – FWB:6A3A - TradingView — Track All Markets
Autolus Therapeutics (NASDAQ:AUTL) Price Target Raised to $11.00 at Needham & Company LLC - Defense World
Autolus Therapeutics (NASDAQ:AUTL) Trading Up 13.5% Following Analyst Upgrade - Defense World
Autolus Therapeutics stock jumps after Needham raises price target By Investing.com - Investing.com South Africa
Autolus Therapeutics stock jumps after Needham raises price target - Investing.com
Is Autolus Therapeutics plc (AUTL) The Best Get Rich Fast Stocks to Buy Right Now? - Finviz
Perpetual Ltd Has $784,000 Position in Autolus Therapeutics PLC Sponsored ADR $AUTL - Defense World
Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
The i-80 Gold Corp (IAUX) had a good session last reading, didn’t it? - uspostnews.com
Autolus Therapeutics’ (AUTL) “Buy” Rating Reiterated at Needham & Company LLC - Defense World
Ryan Richardson joins Autolus Therapeutics board of directors - Investing.com
Autolus Therapeutics plc (AUTL) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Autolus Therapeutics Surges: What’s Next for the Stock? - StocksToTrade
Are These 4 Biotech Stocks Set to Beat Q3 Earnings Estimates? - Yahoo Finance
Needham Keeps Buy Rating on Autolus (AUTL) with a $10 Target - Finviz
Unlocking Oncology’s Future: 3 Trending Cancer Biotech Stocks with ‘Strong Buy’ Ratings - Barchart.com
Gil Blum Analyst Performance at Needham & Company LLC - MarketBeat
Invesco Nasdaq Biotechnology ETF Holdings - Quiver Quantitative
Why Autolus Therapeutics plc (AUTL) is the Penny Stock with the Biggest Upside Potential According to Analysts - Yahoo Finance
AUTL Stock Price and Chart — NASDAQ:AUTL - TradingView — Track All Markets
symbol__ Stock Quote Price and Forecast - CNN
Autolus Therapeutics LtdADR (AUTL) Earnings, Actual EPS, EPS Estimates & Results - Stocktwits
Wells Fargo Maintains Autolus Therapeutics plcADR (AUTL) Overweight Recommendation - Nasdaq
Finanzdaten der Autolus Therapeutics Plc Adr-Aktie (AUTL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
1.44%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):